XML 56 R40.htm IDEA: XBRL DOCUMENT
v3.24.4

REVENUE (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2024
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
| Life Sciences and Applied Markets |  | Agilent CrossLab |  | Diagnostics and Genomics |  | Total
| (in millions)
Year Ended October 31, 2024: |  |  |  |  |  |  |
Americas | $ | 995 |  |  | $ | 674 |  |  | $ | 904 |  |  | $ | 2,573 |
Europe | 811 |  |  | 452 |  |  | 507 |  |  | 1,770 |
Asia Pacific | 1,409 |  |  | 518 |  |  | 240 |  |  | 2,167 |
Total | $ | 3,215 |  |  | $ | 1,644 |  |  | $ | 1,651 |  |  | $ | 6,510 |
Year Ended October 31, 2023: |  |  |  |  |  |  |
Americas | $ | 1,099 |  |  | $ | 634 |  |  | $ | 999 |  |  | $ | 2,732 |
Europe | 851 |  |  | 417 |  |  | 486 |  |  | 1,754 |
Asia Pacific | 1,560 |  |  | 517 |  |  | 270 |  |  | 2,347 |
Total | $ | 3,510 |  |  | $ | 1,568 |  |  | $ | 1,755 |  |  | $ | 6,833 |
Year Ended October 31, 2022: |  |  |  |  |  |  |
Americas | $ | 1,109 |  |  | $ | 567 |  |  | $ | 1,006 |  |  | $ | 2,682 |
Europe | 844 |  |  | 382 |  |  | 473 |  |  | 1,699 |
Asia Pacific | 1,677 |  |  | 503 |  |  | 287 |  |  | 2,467 |
Total | $ | 3,630 |  |  | $ | 1,452 |  |  | $ | 1,766 |  |  | $ | 6,848 |
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
|  | Years Ended October 31,
|  | 2024 |  | 2023 |  | 2022
| (in millions)
Revenue by End Markets |  |  |  |  |  |
Pharmaceutical and Biopharmaceutical |  | $ | 2,242 |  |  | 2,433 |  |  | $ | 2,515 |
Chemicals and Advanced Materials |  | 1,495 |  |  | 1,543 |  |  | 1,521 |
Diagnostics and Clinical |  | 964 |  |  | 966 |  |  | 963 |
Food |  | 592 |  |  | 628 |  |  | 617 |
Academia and Government |  | 567 |  |  | 601 |  |  | 576 |
Environmental and Forensics |  | 650 |  |  | 662 |  |  | 656 |
Total |  | $ | 6,510 |  |  | $ | 6,833 |  |  | $ | 6,848 |
Revenue by Type |  |  |  |  |  |
Instrumentation |  | $ | 2,354 |  |  | 2,742 |  |  | $ | 2,907 |
Non-instrumentation and other |  | 4,156 |  |  | 4,091 |  |  | 3,941 |
Total |  | $ | 6,510 |  |  | $ | 6,833 |  |  | $ | 6,848 |
Contract with Customer, Asset and Liability | The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the years ended October 31, 2023 and 2024:
|  | Contract Liabilities
|  | (in millions)
Ending balance as of October 31, 2022 |  | $ | 557 |
Net revenue deferred in the period |  | 488 |
Revenue recognized that was included in the contract liability balance at the beginning of the period |  | (409) |
Change in deferrals from customer cash advances, net of revenue recognized |  | (28) |
Currency translation and other adjustments |  | 8 |
Ending balance as of October 31, 2023 |  | $ | 616 |
Net revenue deferred in the period |  | 469 |
Revenue recognized that was included in the contract liability balance at the beginning of the period |  | (448) |
Change in deferrals from customer cash advances, net of revenue recognized |  | (9) |
Contract liabilities acquired in business combinations |  | 70 |
Currency translation and other adjustments |  | 3 |
Ending balance as of October 31, 2024 |  | $ | 701 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration